Preclinical Toxicology Studies | Charles River

general toxicology 

Charles River has performed general toxicology safety evaluation studies for the pharmaceutical, chemical, agrochemical, and consumer product industries for decades. This experience has produced a wealth of knowledge that we can now use to advise and conduct standard and novel toxicology study designs as well as to deal with unexpected findings or toxicity issues during the course of your program.

Our carcinogenicity toxicology studies in rodents and toxicity studies in both rodent and non-rodent species are performed in full compliance with Good Laboratory Practice (GLP) regulations. In addition, all protocols are designed to meet the regulatory requirements of the various countries in which the products are to enter clinical trials or be marketed.

Study Options

Routes of administration:

  • Oral (gavage, diet, and capsule)
  • Parenteral (intravenous, subcutaneous, intradermal, intramuscular, and intraperitoneal)
  • Dermal
  • Intranasal
  • Intravaginal and intrapenile
  • Rectal
  • Ocular
  • Intra-articular


Species:

  • Rodent
  • Non-rodent 

 
Duration:

  • Acute to chronic toxicology studies
  • Two-year carcinogenicity
  • Six-month rasH2, Tg.AC and P53 transgenic
  • In utero exposure/neurobehavioral studies

Support Services

  • Analytical chemistry for dose formulation analysis
  • Bioanalytical chemistry sample assays for drug concentration
  • Toxicokinetics and pharmacokinetics
  • Specialized statistical analyses
  • Scientific and strategic consulting


Additional information about our General Toxicology capabilities is available in The SourceSM, o
ur new online scientific and educational information center. To register for The SourceSM, please click here. If you are already a member, click here to login.

If you have any questions, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.